Gemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C).
Investigated for use/treatment in atherosclerosis, cardiovascular disorders, and hyperlipidemia.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.